The mission of MediPines is to advance respiratory medicine by providing physiology-based respiratory devices that enhance clinical effectiveness and achieve better patient outcomes.
MediPines products are produced in our FDA-registered, MDSAP ISO13485:2016 certified manufacturing facility in California.
Follow Our Journey
MediPines is pleased to announce that their AGM100 device has been awarded the prestigious Silver Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence Awards. The Medical Design Excellence Awards are an esteemed award program recognizing cutting-edge achievements in medical product design and celebrating the industry's foremost manufacturers designing and engineering groundbreaking medical devices that are changing patient care worldwide.
ORANGE COUNTY, Calif., April 27, 2021 /PRNewswire/ — We are pleased to announce that MediPines AGM100™, a non-invasive pulmonary gas exchange analyzer, was selected as a finalist in the 2021 Medical Design Excellence Awards (MDEA). The MDEAs is the premier design competition in the MedTech industry organized by MD+DI and recognizes the significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.
MediPines AGM100®’s detection of pulmonary gas exchange impairment is comparable with traditional blood gas method (A-a gradient). A recent clinical study published by medical researchers from UC San Diego School of Medicine has established that an expired breath sampling method is comparable to the long-established blood-based method (ABG) of measuring pulmonary gas exchange efficiency.
Covid-19 respiratory monitoring with MediPines AGM100® <a href="https://c212.net/c/link/?t=0&l=en&o=3022961-1&h=1817045932&u=https%3A%2F%2Fpatient-monitoring.mdtechreview.com%2Fvendors%2Ftop-patient-monitoring-solution-companies-2020.html%23vendor-list&a=MD+Tech+Review" rel="noreferrer noopener" target="_blank">MD Tech Review</a>, a premier medical innovation magazine, has voted MediPines as a 2020 Top Ten Patient Monitoring Solution Provider. MediPines' innovative respiratory technology, GM100®, is making a positive impact in hospitals battling Covid-19. This industry recognition came about as MediPines introduced the AGM100®, an advanced respiratory monitoring system, commercially in the US and Canada earlier this year.
Freeman Lung Clinic, in Joplin, Missouri, has partnered with MediPines, a respiratory medical device company, to provide patients and medical staff with a new innovative way of evaluating lung function. The MediPines respiratory monitoring system, AGM100®, provides direct respiratory measurements allowing the medical team to better understand how well their patients' lungs are functioning. This critical knowledge is essential in improving the outcomes of those who suffer from respiratory conditions such as COPD, lung cancer, and other respiratory diseases.